|
|
 |
Vaccine
Information Statements
VISs by vaccine
Meningococcal
VIS [PDF]
Published
January 28, 2008
You are encouraged
to distribute the up-to-date English-language VIS (above) at the same time
as the translation.
Translations: Up-to-date
Translations: Out-of-date
The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current English-language
version of the following VISs.
|
 |
|
|
|
|
Translations
of the October 7, 2005, Meningococcal VIS
These translations do not
contain the following CDC updates:
- The Guillain-Barre Syndrome
(second bullet just above section 6) was changed slightly: "a few"
was replaced by "some" to reflect the additional cases that were
reported.
Translations of the
March 31, 2000, Meningococcal VIS
This translation does not contain the following
CDC updates:
- The Guillain-Barre Syndrome
(second bullet just above section 6) was changed slightly: "a
few" was replaced by "some" to reflect the additional
cases that were reported.
- Section 5: Under severe
problems, CDC added information about a possible connection to Guillain-Barre
Syndrome.
- Section 1: CDC changed
the words to say, "Of those who live, another 11%-19% lose their
arms or legs..."
- Section 3: There are new
recommendations for MCV4. CDC has added that meningococcal vaccine
is recommended for college freshman living in dormitories and microbiologists
who are routinely exposed to meningococcal bacteria.
- Section 4: It says MCV4
is a new vaccine that has not been studied in
pregnant women as much as
MPSV4
has.
- Section 5: There is some
more information about MCV4.
This page was updated on January 28,
2008 |
|
|
IAC Home